CY1106781T1 - Περιορισμενα ως προς τη διαμορφωση κυκλοποιημενα στην κυρια αλυσιδα αναλογα σωματοστατινης - Google Patents
Περιορισμενα ως προς τη διαμορφωση κυκλοποιημενα στην κυρια αλυσιδα αναλογα σωματοστατινηςInfo
- Publication number
- CY1106781T1 CY1106781T1 CY20071101021T CY071101021T CY1106781T1 CY 1106781 T1 CY1106781 T1 CY 1106781T1 CY 20071101021 T CY20071101021 T CY 20071101021T CY 071101021 T CY071101021 T CY 071101021T CY 1106781 T1 CY1106781 T1 CY 1106781T1
- Authority
- CY
- Cyprus
- Prior art keywords
- main chain
- somatostatin
- somatostatin analogues
- conformation
- disclosed
- Prior art date
Links
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 4
- 229940075620 somatostatin analogue Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 108050001286 Somatostatin Receptor Proteins 0.000 abstract 1
- 102000011096 Somatostatin receptor Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
- G01R31/28—Testing of electronic circuits, e.g. by signal tracer
- G01R31/317—Testing of digital circuits
- G01R31/3181—Functional testing
- G01R31/31816—Soft error testing; Soft error rate evaluation; Single event testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
- G01R31/28—Testing of electronic circuits, e.g. by signal tracer
- G01R31/317—Testing of digital circuits
- G01R31/3181—Functional testing
- G01R31/3185—Reconfiguring for testing, e.g. LSSD, partitioning
- G01R31/318533—Reconfiguring for testing, e.g. LSSD, partitioning using scanning techniques, e.g. LSSD, Boundary Scan, JTAG
- G01R31/318541—Scan latches or cell details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Αποκαλύπτονται νέα πεπτίδια τα οποία είναι περιορισμένα ως προς τη διαμόρφωση ανάλογα σωματοστασίνης με κυκλοποιημένη κύρια αλυσίδα, έχοντας υποδοχέα σωματοστασίνης υπότυπος επιλεκτικότητας. Αυτά τα στοιχεία της επιλεκτικότητας του υπότυπου υποδοχέα παρέχουν στοιχεία έχοντας βελτιώσει τη θεραπευτική χρήση. Μέθοδοι για σύνθεση των αναλόγων σωματοστασίνης και για προσεχτική εξέταση των αναλόγων σωματοστασίνης αποκαλύπτονται επίσης. Επίσης, αποκαλύπτονται φαρμακευτικές συνθέσεις περιλαμβάνοντας ανάλογα σωματοστάσης και μέθοδοι για τη χρήση τέτοιων ενώσεων.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/100,360 US6051554A (en) | 1995-06-07 | 1998-06-19 | Conformationally constrained backbone cyclized somatostatin analogs |
US09/203,389 US6355613B1 (en) | 1996-07-31 | 1998-12-02 | Conformationally constrained backbone cyclized somatostatin analogs |
PCT/IL1999/000329 WO1999065508A1 (en) | 1998-06-19 | 1999-06-15 | Conformationally constrained backbone cyclized somatostatin analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106781T1 true CY1106781T1 (el) | 2012-05-23 |
Family
ID=26797065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071101021T CY1106781T1 (el) | 1998-06-19 | 2007-08-01 | Περιορισμενα ως προς τη διαμορφωση κυκλοποιημενα στην κυρια αλυσιδα αναλογα σωματοστατινης |
Country Status (14)
Country | Link |
---|---|
US (3) | US6355613B1 (el) |
EP (1) | EP1085896B1 (el) |
JP (1) | JP4637352B2 (el) |
KR (1) | KR100689402B1 (el) |
AT (1) | ATE362371T1 (el) |
AU (1) | AU747515B2 (el) |
CA (1) | CA2335488C (el) |
CY (1) | CY1106781T1 (el) |
DE (1) | DE69936100T2 (el) |
DK (1) | DK1085896T3 (el) |
ES (1) | ES2288029T3 (el) |
IL (1) | IL139956A0 (el) |
NZ (1) | NZ508956A (el) |
WO (1) | WO1999065508A1 (el) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6841533B1 (en) | 1995-12-07 | 2005-01-11 | Peptor Limited | Conformationally constrained backbone cyclized interleukin-6 antagonists |
US6355613B1 (en) | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
CA2284459C (en) * | 1999-10-04 | 2012-12-11 | Neokimia Inc. | Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
GB0018891D0 (en) | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
AU2001288847A1 (en) * | 2000-09-07 | 2002-03-22 | Biosyntema Inc. | Conformationally constrained labeled peptides for imaging and therapy |
CA2433785C (en) * | 2001-01-12 | 2009-08-04 | Michael Dewitt Culler | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
DE60226419D1 (de) * | 2001-03-08 | 2008-06-19 | Univ Tulane | Somatostatin-antagonisten |
MXPA03009048A (es) * | 2001-04-09 | 2004-02-12 | Univ Tulane | Agonistas de la somatostatina. |
EP1283216A1 (en) * | 2001-08-10 | 2003-02-12 | Mallinckrodt Inc. | Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
AU2002359359A1 (en) * | 2001-12-28 | 2003-07-24 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
IL148921A0 (en) * | 2002-03-26 | 2002-09-12 | Peptor Ltd | Photo active backbone cyclized somatostatin analogs for optical imaging and photodynamic therapy |
IL150384A0 (en) * | 2002-06-24 | 2002-12-01 | Peptor Ltd | Radiolabelled somatostatin analogs backbone cyclized through metal complexation |
JP4928263B2 (ja) | 2003-07-31 | 2012-05-09 | トランザイム・ファーマ | ペプチド結合サロゲートを組み入れた空間的に規定された大環状分子 |
GB0318682D0 (en) | 2003-08-08 | 2003-09-10 | Novartis Ag | Organic compounds |
ITFI20040057A1 (it) * | 2004-03-10 | 2004-06-10 | Mauro Giuntini | Analoghi della somatostatina |
US20050287557A1 (en) * | 2004-05-10 | 2005-12-29 | Suad Efendic | Methods for identifying compounds for treating diabetes mellitus |
US20070025910A1 (en) | 2005-07-29 | 2007-02-01 | Norenberg Jeffrey P | Anticancer therapy |
WO2007093999A1 (en) * | 2006-02-15 | 2007-08-23 | Intec Pharma Ltd. | A gastro-retentive system for the delivery of macromolecules |
CN1904150B (zh) * | 2006-08-01 | 2010-07-28 | 华东师范大学 | 一种人胰高血糖素样肽-1衍生物及其固相化学合成 |
RU2010114010A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | Применение октреотида в качестве терапевтического средства |
US20120270774A1 (en) | 2009-08-28 | 2012-10-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Macrocyclic compounds, compositions comprising them and methods for preventing or treating hiv infection |
EP2604281B1 (en) * | 2011-12-14 | 2014-07-30 | Centre National de la Recherche Scientifique (CNRS) | Clicked somatostatin conjugated analogs for biological applications |
EP2807182A1 (en) | 2012-01-23 | 2014-12-03 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Stabilized peptide helices for inhibiting dimerization of chemokine c motif receptor 2 (ccr2) |
US9371282B2 (en) | 2013-05-17 | 2016-06-21 | Centrexion Therapeutics Corporation | Somatostatin receptor subtype 4 (SSTR4) agonists |
WO2015087334A1 (en) | 2013-12-15 | 2015-06-18 | Yissum Research Develoment Company Of The Hebrew University Of Jerusalem Ltd. | Viperistatin-derived peptides and uses thereof |
EP3135686A1 (en) * | 2015-08-28 | 2017-03-01 | Latvian Biomedical Research and Study Centre | Novel recombinant cyclized human growth hormone |
EP3405429B1 (en) * | 2016-01-21 | 2021-07-28 | Ramot at Tel-Aviv University Ltd. | Formation of functionalized nanoparticles by supramolecular co-assembly |
WO2017141106A1 (en) * | 2016-02-16 | 2017-08-24 | Strongbridge Biopharma plc | Veldoreotide with poor solubitliy in physiological conditions for use in the treatment of acromegaly, acromegaly cancer, sst-r5 expressing tumors, type 2 diabetes, hyperglycemia, and hormone-related tumors |
EP3464325A1 (en) | 2016-06-07 | 2019-04-10 | Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | Backbone cyclized inhibitory peptides of myeloid differentiation factor 88 (myd88) |
US11261215B2 (en) | 2017-09-19 | 2022-03-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Somatostatin prodrugs |
US20220119474A1 (en) | 2019-02-21 | 2022-04-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Par4 derived peptides, analogs and uses thereof |
WO2022003673A1 (en) | 2020-06-30 | 2022-01-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Humanin analogs and uses thereof |
TW202400577A (zh) | 2021-09-14 | 2024-01-01 | 美商美國禮來大藥廠 | Sstr4促效劑鹽 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4011182A (en) | 1975-03-21 | 1977-03-08 | American Home Products Corporation | Cyclic undecapeptide analogs of somatostatin and intermediates |
US3988304A (en) | 1975-08-25 | 1976-10-26 | American Home Products Corporation | Cyclic dodecapeptide derivatives of somatostatin and intermediates thereof |
US4054558A (en) | 1976-05-24 | 1977-10-18 | American Home Products Corporation | Cyclic dodecapeptide and intermediates therefor |
SU798098A1 (ru) | 1977-12-14 | 1981-01-23 | Ордена Трудового Красного Знамениинститут Органического Синтезаан Латвийской Ccp | Циклический аналог брадикинина,обла-дАющий СпОСОбНОСТью СОздАВАТь пРОлОНги-РОВАННый дЕпРЕССОРНый эффЕКТ B эКСпЕРиМЕН-TE ,A ТАКжЕ ВАСКул РНую пРОНи-цАЕМОСТь B эКСпЕРиМЕНТЕ |
US4191754A (en) | 1979-02-28 | 1980-03-04 | Merck & Co., Inc. | Bicyclic somatostatin analogs |
US4310518A (en) | 1979-10-31 | 1982-01-12 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
US4235886A (en) | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
DE3062075D1 (en) * | 1979-11-27 | 1983-03-24 | Sandoz Ag | Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use |
US4369179A (en) * | 1979-12-14 | 1983-01-18 | Ciba-Geigy Corporation | Acylpeptides |
DE3845000C2 (de) * | 1987-07-10 | 1998-11-19 | Novartis Ag | Anwendung von Octreotid zur Behandlung von Brustkrebs |
US4923963A (en) | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
US5073541A (en) * | 1987-11-18 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Treatment of small cell lung cancer with somatostatin analogs |
EP0334244A3 (en) | 1988-03-25 | 1991-05-29 | The Procter & Gamble Company | Bradykinin antagonist peptides |
EP0336779A3 (en) | 1988-04-08 | 1991-08-21 | Scripps Clinic And Research Foundation | Polypeptides stabilized by covalent hydrogen bond replacements |
IE63490B1 (en) | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
US5753627A (en) * | 1988-12-05 | 1998-05-19 | Novartis Ag | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
HU207104B (en) * | 1991-01-25 | 1993-03-01 | Biosignal Kutato Fejlesztoe Kf | Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds |
CA2102633A1 (en) | 1991-06-03 | 1992-12-04 | Peter H. Cox | Radiolabelled somatostatin derivatives, their preparation and use |
DE4119544C1 (el) | 1991-06-13 | 1992-10-15 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig, De | |
US5364851A (en) | 1991-06-14 | 1994-11-15 | International Synthecon, Llc | Conformationally restricted biologically active peptides, methods for their production and uses thereof |
US5225180A (en) * | 1991-09-10 | 1993-07-06 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
US6117974A (en) * | 1991-10-02 | 2000-09-12 | Peptor Limited | Libraries of backbone-cyclized peptidomimetics |
IL99628A (en) | 1991-10-02 | 2004-07-25 | Yissum Res Dev Co | Processes for the preparation of cyclic peptides, and pharmaceutical compositions containing them |
CA2129033A1 (en) | 1992-02-05 | 1993-08-19 | Leon Lyle | Radiolabelled peptide compounds |
US5411943A (en) * | 1992-02-25 | 1995-05-02 | Biomeasure, Inc. | Hepatoma treatment with somatostatin analogs |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
US5371070A (en) | 1992-11-09 | 1994-12-06 | The Salk Institute For Biological Studies | Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins |
CA2113121A1 (en) | 1993-01-12 | 1994-07-13 | Rainer Albert | Peptides |
DE69426673T2 (de) * | 1993-06-23 | 2001-09-20 | Diatide Inc | Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung |
US5449761A (en) * | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
IL109943A (en) * | 1994-06-08 | 2006-08-01 | Develogen Israel Ltd | Conformationally constrained backbone cyclized peptide analogs |
US5597894A (en) * | 1995-06-05 | 1997-01-28 | The Louisiana State University Medical Center Foundation | Multi-tyrosinated somatostatin analogs |
US6051554A (en) * | 1995-06-07 | 2000-04-18 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
US5770687A (en) * | 1995-06-07 | 1998-06-23 | Peptor Limited | Comformationally constrained backbone cyclized somatostatin analogs |
US6355613B1 (en) * | 1996-07-31 | 2002-03-12 | Peptor Limited | Conformationally constrained backbone cyclized somatostatin analogs |
US6025372A (en) * | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
US6335613B1 (en) * | 2000-12-04 | 2002-01-01 | Abb T&D Technology Ltd. | Versatile power flow transformers for compensating power flow in a transmission line |
-
1998
- 1998-12-02 US US09/203,389 patent/US6355613B1/en not_active Expired - Lifetime
-
1999
- 1999-06-15 EP EP99957020A patent/EP1085896B1/en not_active Expired - Lifetime
- 1999-06-15 JP JP2000554387A patent/JP4637352B2/ja not_active Expired - Fee Related
- 1999-06-15 AT AT99957020T patent/ATE362371T1/de active
- 1999-06-15 KR KR1020007014431A patent/KR100689402B1/ko not_active IP Right Cessation
- 1999-06-15 ES ES99957020T patent/ES2288029T3/es not_active Expired - Lifetime
- 1999-06-15 DK DK99957020T patent/DK1085896T3/da active
- 1999-06-15 IL IL13995699A patent/IL139956A0/xx unknown
- 1999-06-15 DE DE69936100T patent/DE69936100T2/de not_active Expired - Lifetime
- 1999-06-15 AU AU42884/99A patent/AU747515B2/en not_active Ceased
- 1999-06-15 WO PCT/IL1999/000329 patent/WO1999065508A1/en active IP Right Grant
- 1999-06-15 NZ NZ508956A patent/NZ508956A/xx not_active IP Right Cessation
- 1999-06-15 CA CA2335488A patent/CA2335488C/en not_active Expired - Lifetime
-
2000
- 2000-12-13 US US09/734,583 patent/US6930088B2/en not_active Expired - Fee Related
-
2004
- 2004-08-12 US US10/916,522 patent/US7060679B2/en not_active Expired - Lifetime
-
2007
- 2007-08-01 CY CY20071101021T patent/CY1106781T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2288029T3 (es) | 2007-12-16 |
JP2002518339A (ja) | 2002-06-25 |
US20050043226A1 (en) | 2005-02-24 |
CA2335488C (en) | 2011-08-23 |
DK1085896T3 (da) | 2007-09-10 |
EP1085896A4 (en) | 2005-04-06 |
AU4288499A (en) | 2000-01-05 |
ATE362371T1 (de) | 2007-06-15 |
US6930088B2 (en) | 2005-08-16 |
AU747515B2 (en) | 2002-05-16 |
IL139956A0 (en) | 2002-02-10 |
NZ508956A (en) | 2003-06-30 |
JP4637352B2 (ja) | 2011-02-23 |
US7060679B2 (en) | 2006-06-13 |
DE69936100T2 (de) | 2008-02-07 |
CA2335488A1 (en) | 1999-12-23 |
EP1085896A1 (en) | 2001-03-28 |
WO1999065508A1 (en) | 1999-12-23 |
KR100689402B1 (ko) | 2007-03-08 |
KR20010071523A (ko) | 2001-07-28 |
DE69936100D1 (de) | 2007-06-28 |
EP1085896B1 (en) | 2007-05-16 |
US6355613B1 (en) | 2002-03-12 |
US20020052315A1 (en) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106781T1 (el) | Περιορισμενα ως προς τη διαμορφωση κυκλοποιημενα στην κυρια αλυσιδα αναλογα σωματοστατινης | |
CY1106708T1 (el) | Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα | |
CY1105763T1 (el) | Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους | |
ES2154167A1 (es) | Aminoderivados ciclicos antagonistas del receptor ccr-3. | |
ATE363911T1 (de) | Zyklische somatostatin-analoge mit einer hauptkette mit einer gespannten konformation | |
CY1110362T1 (el) | Ν-(2-αρυλαιθυλο)βενζυλαμινες ως ανταγωνιστες του 5-ητ6 υποδοχεα | |
CY1105452T1 (el) | Παραγωγα της κυκλοσπορινης και μεθοδος παρασκευης των εν λογω παραγωγων | |
CY1111504T1 (el) | Αζαδικυκλοαλκανια ως ρυθμιστες του ccr5 | |
DK0918774T3 (da) | Androgenreceptormodulatorforbindelser og fremgangsmåder | |
EA200101177A1 (ru) | Производные индола в качестве антагонистов прогестерона | |
CY1107839T1 (el) | Υδροξαμικα παραγωγα χρησιμα ως αναστολεις δεακετυλασης | |
CY1105963T1 (el) | Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης | |
BR9713147A (pt) | Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal. | |
UY25804A1 (es) | Derivados de 4-aroilpiperidina que son antagonistas de los receptores ccr-3 | |
CY1107590T1 (el) | Ενωσεις απο ουσιες πολυαμιδιου και υπepφθοροαλκυλιου και μιγματα αυτων των ενωσεων με αλλες πολυμepεις ουσιες, μεθοδος για τη συνθεση τους και χρηση | |
BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
CY1106049T1 (el) | Παραγωγα ινδολης | |
TR199902848T2 (xx) | Ergolin t�revleri ve bunlar�n somatostatin resept�r antagonist olarak kullan�mlar� | |
PE20010516A1 (es) | Peptidos ciclicos con afinidad mejorada por los receptores de somatostatina | |
CY1109444T1 (el) | Φαρμακευτικη συνθεση που περιεχει κυκλικα αναλογα σωματοστατινης | |
DE69917278D1 (de) | Heterocyclyl sulphonamid derivate | |
NO985956D0 (no) | Blanding for forbedret opptak av polare medikamenter fra mukosale overflater | |
HUP0000572A2 (hu) | Nukleotid analógot tartalmazó gyógyszerkészítmények és eljárás előállításukra |